INTUITIVE SURGICAL INC

ISRG

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0002010300-26-000011
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026

Summary

Type

Sell

Net shares

-3,658

% of shares

-55.73%

Amount (USD)

$1,815,061

Insider confidence score

8.8 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Extreme scheduled sell (≥25% of shares)
  • Very large sell amount ($1M+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-648.0

Price per Share

$488.10

Amount (USD)

$316,288.80

Acquired/Disposed

Disposed

Shares Owned Before

6,564.0

Shares Owned After

5,916.0

Transaction 2

Security

Common Stock

Action

Sell

Date

2026-03-04

Code

S

Net shares

-2,362.0

Price per Share

$498.68

Amount (USD)

$1,177,883.10

Acquired/Disposed

Disposed

Shares Owned Before

5,916.0

Shares Owned After

3,554.0

Transaction 3

Security

Common Stock

Action

Sell

Date

2026-03-05

Code

S

Net shares

-648.0

Price per Share

$495.20

Amount (USD)

$320,889.60

Acquired/Disposed

Disposed

Shares Owned Before

3,554.0

Shares Owned After

2,906.0

Filing's footnotes

1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $487.18 to $489.94 as follows: 432 shares sold at $487.18 and 216 shares sold at $489.94. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $495.19 to $500.00 as follows: 648 shares sold at $495.19 and 1,714 shares sold at $500.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.